Literature DB >> 19340738

Endoscopic-ultrasound-guided mural trucut biopsy in the investigation of unexplained thickening of esophagogastric wall.

T Thomas1, P V Kaye, K Ragunath, G P Aithal.   

Abstract

BACKGROUND AND AIMS: Esophageal and/or gastric wall thickening raises the possibility of malignancy. Endoscopic-ultrasound-(EUS-)guided targeted biopsy of the thickened wall is possible. We aimed to evaluate the efficacy and safety of EUS-guided mural trucut biopsies (TCB) in detecting underlying malignancy in patients with thickened esophagogastric wall and negative mucosal biopsies.
METHODS: Patients with alarm symptoms referred for EUS-guided sampling after negative endoscopy and mucosal biopsy were included in the study. All patients had radial EUS reporting abnormal thickening of the esophageal/gastric wall. A linear-array echoendoscope and a 19-gauge trucut needle were used for sampling. Clinical and investigatory data were collected prospectively between 2004 and 2008.
RESULTS: Thirty-one patients (20 men) aged 60 - 74 years (median 67 years) were included. All patients had thickened esophageal wall (n = 10), gastric wall (n = 21), or both on radial EUS. Prior to EUS, patients had undergone 1 - 5 endoscopies (median 1.2) and 2 - 8 mucosal biopsies (median 4). The median esophageal and gastric wall thicknesses were 12 and 18 mm respectively. During sampling 1 - 5 needle punctures (median 3) were made. On EUS-TCB, an adequate specimen for histology was obtained in 28/31 patients (90 %). The size of the tissue cores was 4 - 10 mm (median 6mm). Malignancy was confirmed in 16/31 patients (54 %) on histology, and in 11/31 patients (35.4 %) an underlying malignancy was excluded. There was no significant correlation between wall thickness and biopsy size (rho = 0.11, 95 %CI- 0.25 to - 0.45, two-sided P = 0.53). EUS-TCB had sensitivity, specificity, and positive and negative predictive values of 85 %, 100 %, 100 %, and 74 % respectively. There were no immediate or late complications.
CONCLUSIONS: EUS-guided mural TCB is a safe and effective technique in the investigation of esophagogastric wall thickening in patients with alarm symptoms and has high sensitivity and specificity for the diagnosis of a cancer.

Entities:  

Mesh:

Year:  2009        PMID: 19340738     DOI: 10.1055/s-0029-1214470

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  6 in total

1.  Endoscopic ultrasound-guided fine-needle aspiration for duodenal obstruction without a discrete mass.

Authors:  Yousuke Nakai; Hiroyuki Isayama; Naminatsu Takahara; Tsuyoshi Hamada; Dai Mohri; Hirofumi Kogure; Saburo Matsubara; Natsuyo Yamamoto; Minoru Tada; Kazuhiko Koike
Journal:  Dig Dis Sci       Date:  2014-11-28       Impact factor: 3.199

Review 2.  A quarter century of EUS-FNA: Progress, milestones, and future directions.

Authors:  Irina Mihaela Cazacu; Adriana Alexandra Luzuriaga Chavez; Adrian Saftoiu; Peter Vilmann; Manoop S Bhutani
Journal:  Endosc Ultrasound       Date:  2018 May-Jun       Impact factor: 5.628

3.  Detection of Incidental Esophageal Cancers on Chest CT by Deep Learning.

Authors:  He Sui; Ruhang Ma; Lin Liu; Yaozong Gao; Wenhai Zhang; Zhanhao Mo
Journal:  Front Oncol       Date:  2021-09-16       Impact factor: 6.244

Review 4.  How good is fine needle aspiration? What results should you expect?

Authors:  Pierre Eisendrath; Mostafa Ibrahim
Journal:  Endosc Ultrasound       Date:  2014-01       Impact factor: 5.628

Review 5.  Endoscopic ultrasound-guided fine needle aspiration cytology and biopsy in the evaluation of lymphoma.

Authors:  Antonio Z Gimeno-García; Ahmed Elwassief; Sarto C Paquin; Anand V Sahai
Journal:  Endosc Ultrasound       Date:  2012-04       Impact factor: 5.628

6.  Endoscopic Ultrasound-guided Fine Needle Aspiration for the Diagnosis of Duodenal Stenosis Due to Urothelial Carcinoma.

Authors:  Iori Motoo; Takayuki Ando; Hiroshi Mihara; Shinichi Tanaka; Sohachi Nanjo; Shinya Kajiura; Haruka Fujinami; Kosuke Takahashi; Ichiro Yasuda
Journal:  Intern Med       Date:  2020-09-19       Impact factor: 1.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.